UK NSC opens consultation on draft prostate cancer screening recommendation
The UK NSC has opened a public consultation on the evidence relating to screening for prostate cancer.
Mike is the head of UK NSC transparency and public understanding. A former journalist, he has worked in screening since 2010.
The UK NSC has opened a public consultation on the evidence relating to screening for prostate cancer.
The UK NSC has opened a consultation on the evidence relating to antenatal and newborn screening for Fragile X syndrome.
The UK NSC has 15 vacancies to fill on 3 of its expert advisory groups.
The UK National Screening Committee has opened a consultation on a recommendation to continue the in-service evaluation of newborn screening for SCID in NHS services.
Would you like to be involved in a UK NSC stakeholder focus group?
Many thanks to everyone who responded to the UK NSC stakeholder survey. We will analyse the results and use them to inform any changes needed to the UK NSC stakeholder engagement strategy and activities.
The National Institute for Health Research is investing millions of pounds to provide the UK NSC with dedicated research expertise.
Well over 1 million babies have now been screened for severe combined immune deficiency (SCID) since the September 2021 launch of an in-service evaluation (ISE) in NHS services.
Minutes published of UK NSC meeting held on 21 November 2024.
The latest meeting of the SMA Screening In-service evaluation Partnership Board heard that interim results of a new modelling study into SMA screening for the UK context had been presented to a stakeholder workshop.
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the 4 UK countries about all aspects of population screening and supports implementation of
screening programmes.